Mortimer Ian
Xenon Pharmaceuticals Inc. · PRESIDENT & CEO
Mortimer Ian is listed in filings as PRESIDENT & CEO at Xenon Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Mar 13, 2026, including sale activity. Recent filings connect the profile to Xenon Pharmaceuticals Inc. (XENE). The current snapshot covers public activity from Jan 27, 2025 to Mar 13, 2026. Reported amounts are shown as $403.6K to $4.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.